Diagnostic Dye — Vitreoretinal Surgery / ICG Angiography
Pregnancy: Use with caution — iodine component; limited data; avoid unless clearly necessary
Indocyanine Green (Intravitreal Chromovitrectomy)
Brand names: IC-Green
Adult dose
Dose: ICG angiography: 25 mg IV bolus; Chromovitrectomy: 0.5–1 mg/mL diluted solution applied to internal limiting membrane (ILM) intraoperatively
Route: Intravenous (angiography) or Intravitreal/retinal surface (vitreoretinal surgery)
Frequency: Single use (angiography); single intraoperative application (surgery)
Max: 25 mg IV (angiography); lowest effective concentration for ILM staining
ICG angiography: IV injection, imaging within 1–3 minutes (peak choroidal fluorescence). Chromovitrectomy: diluted ICG applied to retinal surface to stain the ILM for macular hole surgery — MUST use preservative-free, low-concentration preparation to avoid retinal toxicity.
Paediatric dose
Dose: 0.1–0.3 mg/kg
Route: IV (angiography)
Frequency: Single injection
Max: 25 mg total
Paediatric indications — under specialist guidance; angiography for suspected choroidal neovascularisation
Dose adjustments
Renal
Use with caution — ICG is entirely hepatically eliminated; renal impairment is less relevant. However, ICG angiography contrast may cause allergic reactions
Hepatic
Use with caution in hepatic impairment — ICG is exclusively liver-extracted; delayed clearance; diagnostic accuracy of liver function test (ICG clearance test) is altered
Paediatric weight-based calculator
Paediatric indications — under specialist guidance; angiography for suspected choroidal neovascularisation
Clinical pearls
- ICG angiography vs fluorescein angiography: fluorescein angiography visualises retinal vasculature; ICG angiography visualises CHOROIDAL vasculature (ICG is protein-bound and does not leak from fenestrated choriocapillaris as readily as fluorescein) — used for PCV, central serous chorioretinopathy, and occult CNV diagnosis
- Retinal toxicity in vitreoretinal surgery: when ICG is used to stain the ILM during macular hole surgery — high concentrations cause direct retinal ganglion cell toxicity and visual field defects; strict concentration control (<0.5 mg/mL) and short exposure time are mandatory
- Shelf life after reconstitution: reconstituted ICG degrades rapidly — use within 10 hours; check for precipitation before use
- Iodine allergy screening MANDATORY before IV angiography — anaphylaxis, although rare, can be fatal; resuscitation equipment must be immediately available
- ICG liver function test: ICG clearance is used as a sensitive measure of hepatic reserve (in liver surgery planning); this is distinct from its ophthalmic use but illustrates the drug's unique hepatic elimination
Contraindications
- Iodine allergy — ICG contains sodium iodide
- Shellfish allergy (cross-reactivity with iodine compounds)
- High-concentration intravitreal use — retinal toxicity
Side effects
- Allergic reactions — mild (nausea) to anaphylaxis (rare, ~1:40,000 IV); higher risk in iodine/shellfish allergy
- Retinal toxicity with high-concentration intravitreal use — ILM damage, visual field defects reported with concentrations >0.5 mg/mL
- Green discolouration of stool and urine for 24 hours (normal)
- Transient nausea (IV angiography)
Interactions
- Iodine-containing contrast agents — additive iodine load; screen for allergy
- Heparin — may affect ICG binding
Monitoring
- Allergy history before IV use
- Vital signs during IV angiography
- Postoperative visual field assessment after ILM peeling with ICG
Reference: BNFc; BNF 90; RCOphth ICG Angiography Guidelines; Haritoglou et al. Retina Review (ICG Toxicity); SPC IC-Green. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- ASA Physical Status Classification · Pre-operative Risk
- Revised Cardiac Risk Index (RCRI / Lee Index) · Perioperative Risk
- Revised Cardiac Risk Index (RCRI) · Pre-operative Risk
- EuroSCORE II · Prognosis
- TIMI Risk Score for UA/NSTEMI · ACS
- Gupta Perioperative Risk for MI or Cardiac Arrest (MICA) · Perioperative Risk
Pathways
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme